Intended Use

The MAGNETOM system is indicated for use as a magnetic resonance diagnostic device (MRDD) that produces transverse, sagittal, coronal and oblique cross sectional images, spectroscopic images and/or spectra, and that displays the internal structure and/or function of the head, body, or extremities. It may be used for imaging during interventional procedures with compatible devices and usable contrast agents.

Technology

The device consists of hardware and software features, including new software syngo MR XA50A and transferred hardware such as the Nexaris Dockable Table, Head Frame, Nexaris Spine 36 coil, and Beat Sensor for cardiac triggers. Software features include advanced pulse sequences (e.g., SVS_EDIT, BEAT_FQ_nav, GRE_WAVE), deep learning-based reconstruction algorithms (Deep Resolve Swift Brain, Deep Resolve Boost), motion correction methods, and workflow assists for prostate and peripheral angiography imaging.

Performance

Performance testing involved verification and validation of transferred hardware and software features, demonstrating that the devices perform as intended and are substantially equivalent to predicate devices. No additional clinical tests were performed. Risk management and compliance with international standards ensure safety and effectiveness.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    3/31/2022

    29 days
  • 2

    FDA Approval

    4/29/2022

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.